Tech Company Financing Transactions
Vivex Biomedical Funding Round
Private investors participated in a $6.6 million Series A funding round for Vivex Biomedical. The funding round closed on 1/5/2016.
Transaction Overview
Company Name
Announced On
1/5/2016
Transaction Type
Venture Equity
Amount
$6,609,235
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 42 investors participated in the offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3200 Windy Hill Rd. 1650W
Atlanta, GA 30339
USA
Atlanta, GA 30339
USA
Phone
Website
Email Address
Overview
Vivex Biomedical, Inc., a biomedical company, develops implant technology and stem cell therapies. The company was formerly known as Vivex Biologix, Inc. and changed its name to Vivex Biomedical, Inc. in November 2012. Vivex Biomedical, Inc. was founded in 2012 and is based in Marietta, Georgia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tracy Anderson
Chief Operating Officer
Lou Barnes
Chief Scientific Officer
Timothy Ganey
VP - General Counsel
Reinaldo Pascual
VP - Marketing
Holly Tally
Browse more venture capital transactions:
Prev: 1/5/2016: Greenwave Systems venture capital transaction
Next: 1/5/2016: TARA Biosystems venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs